Legal & General Group Plc purchased a new position in Ingredion Incorporated (NYSE:INGR – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 87,535 shares of the company’s stock, valued at approximately $8,290,000. Legal & General Group Plc owned approximately 0.14% of Ingredion as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also modified their holdings of the company. International Assets Investment Management LLC acquired a new stake in Ingredion in the fourth quarter worth about $30,000. GHP Investment Advisors Inc. acquired a new position in Ingredion during the 1st quarter valued at about $33,000. Los Angeles Capital Management LLC bought a new stake in shares of Ingredion during the 4th quarter worth about $36,000. Bell Investment Advisors Inc bought a new stake in shares of Ingredion during the 2nd quarter worth about $34,000. Finally, Root Financial Partners LLC lifted its stake in shares of Ingredion by 83.7% in the 1st quarter. Root Financial Partners LLC now owns 371 shares of the company’s stock worth $42,000 after acquiring an additional 169 shares during the period. 85.27% of the stock is currently owned by institutional investors.
Insider Activity at Ingredion
In other news, Director David B. Fischer sold 1,662 shares of the firm’s stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $102.31, for a total transaction of $170,039.22. Following the completion of the sale, the director directly owned 19,930 shares of the company’s stock, valued at $2,039,038.30. This trade represents a 7.70% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.60% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on INGR
Ingredion Stock Performance
Shares of INGR opened at $104.30 on Wednesday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.80 and a quick ratio of 1.92. The firm’s 50 day moving average is $101.61 and its 200-day moving average is $106.51. Ingredion Incorporated has a 12-month low of $94.44 and a 12-month high of $130.45. The stock has a market capitalization of $6.58 billion, a P/E ratio of 11.37, a P/E/G ratio of 0.89 and a beta of 0.62.
Ingredion (NYSE:INGR – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $2.82 EPS for the quarter, beating the consensus estimate of $2.71 by $0.11. The business had revenue of $1.85 billion during the quarter, compared to analyst estimates of $1.83 billion. Ingredion had a net margin of 8.21% and a return on equity of 15.40%. The business’s quarterly revenue was up .9% on a year-over-year basis. During the same period in the prior year, the business earned $2.87 earnings per share. Ingredion has set its FY 2026 guidance at 10.300-10.900 EPS. Equities research analysts anticipate that Ingredion Incorporated will post 10.6 EPS for the current fiscal year.
Ingredion Profile
Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.
The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.
Featured Stories
- Five stocks we like better than Ingredion
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Ingredion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingredion and related companies with MarketBeat.com's FREE daily email newsletter.
